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Introduction 
With technological advances saving lives daily, one obstacle still plagues the medical 
community- organ shortages. Over 112,000 patients await a new organ in the United States alone 
and the numbers keep growing (Transplant trends, 2011). Between 2001 and 2010 this disparity 
between the number of patients on the waiting list and the number of organ donors caused over 
7,000 people to lose their lives every year (Death removals, 2011). Although modern medicine 
can keep patients awaiting a new organ living longer, the only way to save lives is to increase the 
number of available organs. One way to solve the organ shortage is to use organs that the 
medical community would have discarded before, or put another way, marginal organs. 
Donors previously thought unable to provide organs are now being considered to 
decrease the disparity between the waiting list and the number of organs available. “Marginal or 
extended criteria donors (ECD) are defined as those with a greater risk of initial poor function or 
graft failure” (Gastaca, 2009, p. 975). Although extended organ criteria are more commonly 
accepted now, there are benefits and risks to consider.  Patients awaiting organs now have 
another choice to make, is a marginal organ worth the risk? It is important to both understand the 
implications of the organ shortage and the benefits and risks of using marginal donor organs. 
Literature Review 
Many factors are considered when choosing an organ. Prolonged organ ischemic time, an 
individual’s age, and non-heart beating donors (NHBDs) are just a few examples of factors that 
play into a surgeon’s decision to use an organ (Busuttil & Tanaka, 2003, p. 651). Time between 
the preservation of the graft and the re-warming of the graft is considered ischemic time. The 
ischemic time is normally a non-negotiable factor when choosing organs. “Grafts with more than 
14 hours of cold ischemia have been associated with a two-fold increase in preservation damage” 
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(Busuttil & Tanaka, 2003, p. 652). However, the transplant community has made ischemic time a 
priority in an effort to increase the number of donor organs available. 
 “Donor age has been steadily increasing over the past decade” (Busuttil & Tanaka, 2003, 
p. 651). Before, organs over fifty years old were “associated with poor graft outcomes” and now 
organs over 60 years are being used (Busuttil & Tanaka, 2003, p. 651). Controlled NHBDs are 
organs taken after “planned withdrawal of life support, most often in an operating room, with a 
donor surgical team present” (Busuttil & Tanaka, 2003, p.653). Uncontrolled NHBDs “either fail 
cardiopulmonary resuscitation and/or arrive dead at the hospital” (Busuttil & Tanaka, 2003, p. 
653). In the past, only controlled NHBDs were considered viable for donation. In a study of 
twenty-four recipients, of both controlled and uncontrolled NHBDs, a survival rate of 93% in 
one year has opened up the possibility of using uncontrolled NHBDs as well (Busuttil & Tanaka, 
2003, p. 653). Seemingly, these singular risks can be minimal but it is rare to have one risk factor 
in a donor organ. 
Beyond general elements, organ specific issues are also considered, such as the fatty liver 
and a kidney with a decreased filtering rate. The increase in obesity in the United States has 
caused the liver transplant community to “expect a further increase in the prevalence of 
steatosis” (Gastaca, 2009, p. 976). In the past, livers with less than thirty percent fat have been 
considered no different than non-fatty livers (Gastaca, 2009, p. 976). In contrast, livers, with 
greater than sixty percent fat, have been discarded because they are associated with higher 
mortality rates (Gastaca, 2009, p. 976). To combat this problem in the liver transplant 
community, matching donors with recipients has never been more important. “Grafts with 
moderate steatosis can be safely used in low risk patients” and they are passed over in patients 
with higher MELD scores (Mullhaupt, Dimitroulis, Gerlach & Clavien, 2007, p.S61). The kidney 
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transplant community has also made an effort to combat the shortage of organs. Kidneys with 
lower creatinine clearance rates have been accepted but depend heavily on the histologic 
condition in the recipient (Pascual, Zamora & Pirsch, 2008, p. 558). “If histological evaluation is 
performed before the kidney allocation”, there is a better chance of graft survival (Pascual et al., 
2008, p. 558). In the end, the organ specific criteria have changed from wasting organs 
considered unfit in the past to using every resource to match donors and recipients for the best 
outcome.  
With a waiting time of over three years for over 36,000 patients, every possible organ 
needs to be assessed (Organ by waiting, 2011). “The use of the high risk, so-called marginal or 
expanded donors, may be the simplest way to increase the donor supply” (Gruttadauria et al., 
2005, p. 2568). The use of these organs can be successful. One study showed that a cold 
ischemic time of less than 8 hours had the long term graft function “equivalent in donors greater 
than 50 years of age” (Busuttil & Tanaka, 2003, p. 652). The marginal donor also opens up 
possibilities for using donors with viral infections, such as hepatitis. In one report, the hepatitis 
positive recipient had a greater survival rate when a hepatitis positive graft was used (Gastaca, 
2009, p.977). Furthermore, transplantation with an ECD for kidney patients may by more 
beneficial for quality of life, especially in elderly patients. “Mortality is decreased with an ECD 
kidney transplant compared with dialysis therapy” (Pascual, Zamora, & Pirsch, 2008, p. 553). 
Another group of patients that would benefit from ECD are diabetes patients. Diabetes patients 
“receiving an ECD kidney transplant after waiting 2 years showed similar life expectancy 
compared with waiting 4 years” for a standard kidney (Pascual et al., 2008, p. 574). Depending 
on the circumstance of the recipient, marginal donors seem the best solution for organ donation 
disparity. 
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With every new medical practice, there are risks to be considered. Although moderate 
steatotic donors are being considered, graft function in the first three days is impaired and can 
cause death (Busuttil & Tanaka, 2003, p. 653). Also, fatty livers are not helpful and should not 
be considered for patients with higher MELD scores. On report suggests that “early post-
transplant survival was significantly reduced when moderately steatotic grafts were used in high-
risk patients” (Gastaca, 2009, p. 976). McCormack showed that using steatotic livers presents a 
higher risk of renal failure that would require hemodialysis in the future (McCormack, 2007, p. 
944). 
 For kidney patients, transplantation has limited the morbidity of longstanding dialysis 
but in the long term, these patients have a shorter graft life (Pascual, Zamora & Pirsch, 2008, p. 
579).  Furthermore, one group of patients that does not benefit from the marginal organ is 
retransplanting patients. The morbidity of ECD retransplantation was equal to remaining on the 
waiting list (Pascual, Zamora & Pirsch, 2008, p. 572). The last risk to consider when receiving a 
marginal organ is finance. Patients that received steatotic grafts had much longer ICU and 
hospital stays and increased medical costs overall (McCormack et al., 2007, p. 944). Depending 
on the patient situation, the ECD graft can be dangerous and unnecessary. 
Conclusion 
The use of marginal donors has both benefits and risks. The use of these organs is still too 
new to call it safe. Not enough research has been conducted to speak to the legal and ethical 
aspects of these organs.  Although the medical community is making strides to match donors and 
recipients, is it considered maleficent to knowingly give a patient a sub-par organ? Two different 
ways have been suggested to solve this dilemma. First, “it would be reasonable for transplant 
centers that use marginal donors to establish a ‘secondary list’ of recipients who might be 
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suitable for a marginal graft” (Busuttil & Tanaka, 2003, p. 658). Second, restrict marginal organs 
in programs with short waiting times and allocate those organs to programs with long waiting 
periods (Pascual, Zamora & Pirsch, 2008, p. 574). Even with these suggestions, the patient must 
be informed of the dangers of using these risky organs. 
The nursing role must also change with the use of ECD in transplantation. Education is 
first and foremost in giving the patient the ability to make this difficult decision. Even the 
decision to transfer to a marginal donor list can be daunting because it is still an unknown 
practice. Also, the nurse must also encourage the use of advance directives. The outcome of 
these transplants is not predictable and the patient needs to be prepared. I believe that with 
optimal donor care and precise matching, using marginal donor organs is more beneficial than 
detrimental to the transplant community. 
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